Skip to main content
. 2011 Dec 8;18(5):265–279. doi: 10.1093/molehr/gar078

Figure 5.

Figure 5

ROCK inhibitor g-H-1152 causes dose-dependent decreases in MYL and MYPT1 phosphorylation in cultured myometrial cells. Resting myometrial cells were treated for 40 min with g-H-1152 at the concentrations shown; 0.1% DMSO was added to control wells. (A) Cell lysates were subjected to immunoblotting for total and phosphorylated MYL and MYPT1, representative blots are shown. Signal from the phospho-specific antibody was normalized to that obtained from the associated total antibody, and was expressed as a percentage of the non-treated value. (B) ppMYL (Thr18/Ser19) levels; (C) pMYL (Ser19) levels; (D) pMYPT1 (Thr853) levels and (E) pMYPT1 (Thr696) levels. Data points represent mean ± SEM, n = 11. Statistical significance was determined using one-way ANOVA and Dunnett's post hoc test; *P < 0.05 and **P < 0.01 compared with non-treated cells.